NCT00097006

Brief Summary

To conduct epidemiological, laboratory, and survey research on volunteer blood donors within the United States to ensure the safety and availability of the United States' blood supply.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Sep 2004

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2004

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 17, 2004

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 18, 2004

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2009

Completed
Last Updated

April 15, 2016

Status Verified

September 1, 2009

Enrollment Period

5 years

First QC Date

November 17, 2004

Last Update Submit

April 14, 2016

Conditions

Acquired Immunodeficiency SyndromeBlood DonorsBlood TransfusionHIV InfectionsHIV-1HIV-2HTLV-IHTLV-IIRetroviridae InfectionsHepatitis, Viral, HumanHepatitis BHepacivirusWest Nile Virus

Eligibility Criteria

AgeUp to 100 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
No eligibility criteria

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Related Publications (1)

  • Mast AE, Schlumpf KS, Wright DJ, Johnson B, Glynn SA, Busch MP, Olbina G, Westerman M, Nemeth E, Ganz T; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomy. Haematologica. 2013 Aug;98(8):1324-30. doi: 10.3324/haematol.2012.070979. Epub 2013 Feb 26.

    PMID: 23445875DERIVED

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeHIV InfectionsRetroviridae InfectionsHepatitis, Viral, HumanHepatitis B

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesHepatitisLiver DiseasesDigestive System DiseasesHepadnaviridae InfectionsDNA Virus Infections

Study Officials

  • Michael Busch

    Vitalant Research Institute

  • Jerome Gottschall

    Blood Center of Southeastern Wisconsin, Inc.

  • Christopher Hillyer

    Emory University

  • Ram Kakaiya

    Institute for Transfusion Medicine

  • Edward Murphy

    University of California, San Francisco

  • Jorge Rios

    American Red Cross Blood Services, New England Region

  • Ronald Sacher

    University of Cincinnati

  • George Schreiber

    Westat, Inc.

Study Design

Study Type
observational
Sponsor Type
NIH

Study Record Dates

First Submitted

November 17, 2004

First Posted

November 18, 2004

Study Start

September 1, 2004

Primary Completion

September 1, 2009

Study Completion

September 1, 2009

Last Updated

April 15, 2016

Record last verified: 2009-09